LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

EntryPoint Capital, LLC's Holding History (CIK: 0001992519)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 207,996 Value ($000) $287 Avg Close — Range —
Q1 2024
Shares 26,727 Value ($000) $60 Avg Close — Range —
Q4 2023
Shares 65,633 Value ($000) $127 Avg Close — Range —